These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway. Anliker-Ort M; Dingemanse J; van den Anker J; Kaufmann P Front Immunol; 2020; 11():599417. PubMed ID: 33362783 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic complement inhibition – from experimental to clinical medicine. Lappegård KT; Bjerre A; Tjønnfjord GE; Mollnes TE Tidsskr Nor Laegeforen; 2015 Oct; 135(19):1745-9. PubMed ID: 26486669 [TBL] [Abstract][Full Text] [Related]
5. The role of complement inhibition in kidney transplantation. Legendre C; Sberro-Soussan R; Zuber J; Frémeaux-Bacchi V Br Med Bull; 2017 Dec; 124(1):5-17. PubMed ID: 29069327 [TBL] [Abstract][Full Text] [Related]
6. The emerging role of complement inhibitors in transplantation. Frémeaux-Bacchi V; Legendre CM Kidney Int; 2015 Nov; 88(5):967-73. PubMed ID: 26376132 [TBL] [Abstract][Full Text] [Related]
7. Complement and the Kidney: An Overview. Thurman JM Adv Chronic Kidney Dis; 2020 Mar; 27(2):86-94. PubMed ID: 32553250 [TBL] [Abstract][Full Text] [Related]
8. Complement inhibitors are not useful in secondary hemolytic uremic syndromes. Duineveld C; Wetzels JFM Kidney Int; 2019 Oct; 96(4):829-833. PubMed ID: 31543154 [No Abstract] [Full Text] [Related]
9. Therapeutic regulation of complement in patients with renal disease - where is the promise? Thurman JM Clin Nephrol; 2012 May; 77(5):413-23. PubMed ID: 22551888 [TBL] [Abstract][Full Text] [Related]